Ethaselen Uses, Dosage, Side Effects and more
Ethaselen is under investigation in clinical trial NCT02166242 (Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers).
Trade Name | Ethaselen |
Generic | Ethaselen |
Type | |
Formula | C16H12N2O2Se2 |
Weight | Average: 422.226 Monoisotopic: 423.922922 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |